Figure 2
From: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
The cumulative cancer incidence of (a) the whole study population, (b) female patients, (c) male patients, (d) subjects ≤65 years old, and (e) subjects >65 years old. The red dashed lines and blue continuous lines show the cumulative cancer incidence of LTRA non-users and LTRA users, respectively. LTRA users had a significantly lower cumulative cancer incidence than LTRA non-users did (p < 0.0001).
